Sanofi India Q2 profit rises 40% at Rs116 crore
Sanofi India's net profit jumped 40.28% at Rs116.3 crore for the second quarter ended 30 September31-10-2017
31-10-2017
Financial Results For Sept 30, 2017
We enclose a copy of the unaudited financial results of the quarter ended 30th September 2017 approved at this Meeting and the Limited Review Report as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for your information.31-10-2017
Financial Results For Sept 30,2017
We enclose a copy of the unaudited financial results of the quarter ended 30th September 2017 approved at the Meeting and the Limited Review Report as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for your information.31-10-2017
Shantha Biotechnics completes delivery of polio vaccine to govt
Shantha Biotechnics, an arm of Sanofi Pasteur, the vaccines division of Sanofi, has supplied 20 million doses of ShanIPV to the government since December 2015. The final shipment from Shantha...24-10-2017
Publication Of Board Meeting Notice
Please find enclosed copies of the Notice of the Board Meeting of the Company published today, in newspapers, Business Standard and Sakal.24-10-2017
Board Meeting On Oct 31, 2017
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, 31st October 2017; inter alia to consider the unaudited financial results for the quarter ended 30th September 2017 (Q3).23-10-2017
Shareholding for the Period Ended September 30, 2017
Sanofi India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here18-10-2017
Compliance Certificate For The Period September 2017
Pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the compliance certificate for the period 1st April 2017 to 30th September 2017.18-10-2017
Statement Of Investor Complaints For Quarter Ended September, 2017
Pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 please find enclosed statement of investor complaints/grievances for the quarter ended 30th September 2017.18-10-2017
Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September 2017
Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. S. N. Ananthasubramanian & Co., Company Secretaries for the half year ended 30th September 2017.18-10-2017